Concepedia

Jianmin Xu

JX

Statistics

Publications

70

Citations

3.1K

H-Index

28

Active since

2000

Affiliations

Fudan University(Current)

Zhongshan Hospital

Sun Yat-sen University

The First Affiliated Hospital, Sun Yat-sen University

Shanghai Cancer Institute

Jianmin Xu is an author at Fudan University specializing in oncology, colorectal cancer, and medicine.

ORCID

Publications per year

2000–2025

70

Publications

70

Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With <i>KRAS</i> Wild-Type Unresectable Colorectal Liver-Limited Metastases

Lechi Ye, Tianshu Liu, Li Ren et al. · Journal of Clinical Oncology · 2013 · 392 citations · Full text

, , +17

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7

Wentao Tang, Meiling Ji, Guodong He et al. · OncoTargets and Therapy · 2017 · 182 citations · Full text

, , +17

Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer

Qingyang Feng, Wenju Chang, Yihao Mao et al. · Clinical Cancer Research · 2019 · 164 citations · Full text

, , +17

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Yihao Mao, Qingyang Feng, Peng Zheng et al. · Cancer Management and Research · 2018 · 145 citations · Full text

, , +17

Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression

Qixia Xu, Qilai Long, Dexiang Zhu et al. · Aging Cell · 2019 · 139 citations · Full text

, , +16

1–5 of 70